EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Endothelial to mesenchymal transition (EndMT) in atherosclerosis: mechanisms, models, and therapies

Iqra Ilyas, Paul C Evans, Bradford C Berk, Stefan Offermanns, Suowen Xu iD

Cardiovascular Research · 2026

DOI: 10.1093/cvr/cvag145 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Research, 2026. Verfasst von Iqra Ilyas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and …. Hauptthemen laut MEDLINE: Endothelial-Mesenchymal Transition, Atherosclerosis, Endothelial Cells, Arteries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 207 Literaturangaben. Gefördert von: National Natural Science Foundation of China, USTC Research Funds of the Double First-Class Initiative, Research Funds of Centre for Leading Medicine and Advanced Technologies of IHM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endothelial to mesenchymal transition (EndMT) has emerged as a key contributor to the development and progression of atherosclerotic cardiovascular disease. Driven by biomechanical, inflammatory, and metabolic cues within the vascular microenvironment, EndMT leads to the loss of endothelial identity and the acquisition of mesenchymal characteristics, thereby promoting vascular dysfunction and plaque progression. In this review, we present a comprehensive and up-to-date (as of 15 April 2026) overview of the molecular drivers and experimental models of EndMT in atherosclerosis and critically evaluate current and emerging therapeutic strategies aimed at modulating this process. Furthermore, we emphasize the unresolved methodological challenges, which include the absence of standardized and quantitative approaches for EndMT detection, and the strong context dependency of existing experimental models. Emerging technologies, including genetic lineage tracing and single-cell transcriptomics, have revealed previously unrecognized cellular heterogeneity, context-dependent functional roles, and sex-specific EndMT signatures within human atherosclerotic plaques. Integrating recent advances in molecular biology, in vivo modelling, and translational research, this review provides a structured framework for understanding the multifaceted role of EndMT in atherosclerosis and outlines key challenges to be addressed to facilitate the translation of basic discoveries into clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial-Mesenchymal TransitionAtherosclerosisEndothelial CellsArteriesHumansAnimalsPlaque, AtheroscleroticSignal TransductionDisease Models, AnimalPhenotypeCardiovascular Agents

Stichwörter der Autor:innen

AtherosclerosisEndothelial to mesenchymal transitionMechanismSignalling pathwaysTherapy

Substanzen

Cardiovascular Agents

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China.
  • Centre for Microvascular Research, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Department of Physical Medicine and Rehabilitation, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
  • Department of Pharmacology, Max Planck Institute for Heart and Lung Research, Ludwigstr. 43, Bad Nauheim 61231, Germany.
  • Anhui Provincial Key Laboratory of Metabolic Health and Panvascular Diseases, Huangshan Rd 443, Hefei 230027, China.

ORCID-Profile: Suowen Xu

Förderung

  • National Natural Science Foundation of China
  • USTC Research Funds of the Double First-Class Initiative
  • Research Funds of Centre for Leading Medicine and Advanced Technologies of IHM

Zitieren

APA

Ilyas, I., Evans, P. C., Berk, B. C., Offermanns, S., & Xu, S. (2026). Endothelial to mesenchymal transition (EndMT) in atherosclerosis: mechanisms, models, and therapies. Cardiovascular Research. https://doi.org/10.1093/cvr/cvag145

Vancouver

Ilyas I, Evans PC, Berk BC, Offermanns S, Xu S. Endothelial to mesenchymal transition (EndMT) in atherosclerosis: mechanisms, models, and therapies. Cardiovascular Research. 2026. doi:10.1093/cvr/cvag145

BibTeX
@article{Ilyas2026,
  author = {Ilyas, Iqra and Evans, Paul C and Berk, Bradford C and Offermanns, Stefan and Xu, Suowen},
  title = {Endothelial to mesenchymal transition (EndMT) in atherosclerosis: mechanisms, models, and therapies},
  journal = {Cardiovascular Research},
  year = {2026},
  doi = {10.1093/cvr/cvag145}
}
Kostenlos starten →